top of page
Search

15 Key Buprenorphine Dosing Recommendations for Jail-Based Treatment Programs



Corrections staff cite diversion of medication for opioid use disorder (MOUD) (e.g., buprenorphine) as a reason for not offering treatment with these medications in jails and prisons. In a 2023 study, researchers from the University of Massachusetts outline key steps MOUD program staff can implement to prevent diversion. The study also provides guidance to corrections and lawmakers as they consider establishing and expanding MOUD treatment in correctional settings.


Comments


bottom of page